Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

Jun 11 • 09:46AM ET

8.47

0.00 0.00 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CCCC CHRS ZNTL ALLO ALEC CLLS ELDN IMRX LENZ GLSI

| Held by: XBI IWM IWN IBB VTI SCHA VXF IWC DFAS PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.67%	Shs Outstand	79.63M	Perf Week	-14.18%
Market Cap	699.39M	Forward P/E	-	EPS next Y	-1.81	Insider Trans	-1.78%	Shs Float	76.24M	Perf Month	107.09%
Enterprise Value	506.60M	PEG	-	EPS next Q	-0.71	Inst Own	102.42%	Short Float	34.04%	Perf Quarter	11.74%
Income	-314.85M	P/S	-	EPS this Y	-5.96%	Inst Trans	-6.04%	Short Ratio	3.53	Perf Half Y	-17.77%
Sales	0.00M	P/B	3.20	EPS next Y	44.44%	ROA	-67.19%	Short Interest	25.95M	Perf YTD	-12.86%
Book/sh	2.64	P/C	2.60	EPS next 5Y	27.37%	ROE	-90.88%	52W High	13.24 -36.03%	Perf Year	-13.39%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 464.67%	Perf 3Y	-62.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.20% 13.06%	Perf 5Y	-75.09%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.88	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	62.57	Recom	3.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	20.86%	Beta	0.91	Target Price	4.67
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	67.12%	Rel Volume	0.27	Prev Close	8.47
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	21.73%	Avg Volume	7.34M	Price	8.47
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	177,234	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)